CNO Financial Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
CNO Financial Group, Inc. filed this Current Report on Form 8-K on April 29, 2024. The filing serves to announce the company's financial results for the quarter ended March 31, 2024. The report incorporates by reference a press release, a Quarterly Financial Supplement, and additional financial information regarding the first quarter of 2024.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached exhibits (Exhibits 99.1, 99.2, and 99.3) which are incorporated by reference but not included in the text of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release and financial supplement for comparative analysis.
Guidance, Outlook, and Risks
This Form 8-K does not contain specific management commentary, forward-looking guidance, or a detailed discussion of risks and contingencies within the main body text. Such information is contained within the referenced exhibits. The filing explicitly states that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other documents unless expressly set forth.
Key Facts for Investor Verification
- Verify the specific revenue and earnings figures in the attached Press Release (Exhibit 99.1) and Quarterly Financial Supplement (Exhibit 99.2).
- Review the First Quarter 2024 Financial and Operating Results (Exhibit 99.3) for detailed operational metrics.
- Note that the information in this 8-K is furnished and not "filed" under Section 18 of the Exchange Act, limiting its liability status compared to standard filings.
- Confirm the trading symbols for the company's securities: Common Stock (CNO), Rights to purchase Series F Junior Participating Preferred Stock, and 5.125% Subordinated Debentures due 2060 (CNOpA), all listed on the New York Stock Exchange.